Prasad R et al., 2008-03: Indian randomized study in 11 children with dapsone-induced methemoglobinemia finding continuous intravenous methylene blue lowered methemoglobin significantly more than intermittent dosing at the same total dose.
Continuous I.V methylene blue therapy causes significant decline in MetHb level and is more effective in treatment of methemoglobinemia as compared to intermittent regimen.
245-7
Prasad R et al., 2008-03: Indian randomized study in 11 children with dapsone-induced methemoglobinemia finding continuous intravenous methylene blue lowered methemoglobin significantly more than intermittent dosing at the same total dose. C9 India (Institute of Medical Sciences, BHU, Varanasi; Indian J Pediatr 75(3):245-7, 2008). Study type: randomized comparison of two dosing schedules, N=11 (5 intermittent, 6 continuous). Dose: same in both groups (amount in the paper, not in abstract). Comparator: intermittent bolus schedule. Funder/conflicts: none declared. Very small sample; the finding is about schedule, not about whether to use methylene blue. Study type: randomized trial.
